MMP9 and rheumatoid arthritis: Articular cartilage and bone degradation are associated with the upregulation of matrix metalloproteinases (MMPs) and osteolytic enzymes, such as MMP-9 and cathepsin K, respectively [45–47], in the serum and synovial fluid of RA patients [48, 49].